KP-102 (growth hormone-releasing peptide-2) attenuates ischemia/reperfusion injury in isolated rat hearts

By Furuta Sadayoshi   Hori Toshimitsu   Ohyama Tadashi  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 373, Iss. 5, 2006-08 ,pp. : 360-366

Springer Publishing Company

Access to resources Recommend Favorite

Studies of KP46 and KP1019 and the Hydrolysis Product of KP1019 in Lipiodol Emulsions: Preparation and Initial Characterizations as Potential Theragnostic Agents

By  

Current Drug Delivery, Vol. 15, Iss. 1, 2018-01 ,pp. : 134-142

Bentham Science Publishers

Access to resources Recommend Favorite

Chicken ghrelin and growth hormone-releasing peptide-2 inhibit food intake of neonatal chicks

By Saito E.-s.   Kaiya H.   Takagi T.   Yamasaki I.   Denbow D.M.   Kangawa K.   Furuse M.  

European Journal of Pharmacology, Vol. 453, Iss. 1, 2002-10 ,pp. : 75-79

Elsevier

Access to resources Recommend Favorite

Lack of association between the 5HT 2A receptor polymorphism (T102C) and unipolar affective disorder in a multicentric European study

By Oswald P.   Souery D.   Massat I.   Del-Favero J.   Linotte S.   Papadimitriou G.   Dikeos D.   Kaneva R.   Milanova V.   Oruc L.   Ivezic S.   Serretti A.   Lilli R.   Van Broeckhoven C.   Mendlewicz J.  

European Neuropsychopharmacology, Vol. 13, Iss. 5, 2003-10 ,pp. : 365-368

Elsevier

Access to resources Recommend Favorite

Ribonucleotide Reductase as One Important Target of [Tris(1,10- phenanthroline)lanthanum(III)] Trithiocyanate (KP772)

By  

Current Cancer Drug Targets, Vol. 9, Iss. 5, 2009-08 ,pp. : 595-607

Bentham Science Publishers

Access to resources Recommend Favorite